Sign up
Pharma Capital
Market: TSX-V
52-week High/Low: C$0.32 / C$0.10
Sector: Health Care, Equipment & Services
Market Cap: C$9.38M

Ventripoint (TSXV: VPT) has redesigned VMS to meet the demands of every market.  Preparing to move beyond the Left and Right Ventricle to become the first platform to offer 3D volumes for all cardiac chambers, with accuracy equivalent to MRI.....all from the convenience of 2D Ultrasound.

VentriPoint Diagnostics Ltd.

Interactive graph

col 3
col 4
col 5
col 6
View full VPT profile View Profile
View All

Executive video interviews


© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.